There’s generic increase in the overall diseases but the sharpest increase can be felt in the Sleeping Aids Market that is currently estimated to be at $60 billion but it is projected to almost double by year 2029.
The report discusses Sleep Aids by their indication including but not limited to Insomnia, Sleep Apnea, Narcolepsy and sleep deprivation. It also discusses all the key market players from Pfizer to SleepMed to Merck & Co and RedMed, Fisher and Paykel, Early Sense and GlaxoSmithKline. The report can be found here: https://www.futurewiseresearch.com/request-sample.aspx?id=266&page=askfordiscount
Today’s stressful lifestyle and a rise in geriatric population is contributing to the growth in Sleep Aid market and demand for insomnia treatment drugs, Quazepam, Zriazolam, Ramelteon, Eszopiclone, Doxepin Hydrochloride, Zaleplon and other drugs of same nature is increasing on a daily basis especially in the North American region but demand for Sleep Aid is higher in other regions such as Europe, Asia, Latin America and Gulf.
Moreover, devices like Positive Airway Pressure types i.e. Bi-level, Auto Adjusting and continuous Positive Airway Pressure are discussed separately and not only that chin straps, Mouth Pieces and Nasal devices are also discussed in greater detail.
Email: [email protected]